2019 November 6

Dr. Fumiichiro Yamamoto receives the Karl Landsteiner Memorial Award and Lectureship

Dr. Fumiichiro Yamamoto has received the prestigious Karl Landsteiner Memorial Award and Lectureship from the American Association of Blood Banks (AABB), the last of the awards that recognize his work on blood groups.

Dr. Fumiichiro Yamamoto, leader of the IJC Immunohematology and Glycobiology research group, has received the Karl Landsteiner Award from the American Association of Blood Banks (AABB) in San Antonio, Texas, USA., on the 22nd of October.

This year, the Karl Landsteiner Award has recognized people who have led instrumental research in the isolation and cloning of the major blood group carrier molecules. Together with Yamamoto, three more scientists have been honored: Dr. David Anstee, from the Bristol Institute for Transfusion Sciences (United Kingdom); Dr. Jean-Pierre Cartron, from Institut National de la Transfusion Sanguine (France); and Dr. Colvin Redman, from the New York Blood Center (United States).

F. Yamamoto is a familiar name in immunohematology textbooks for his seminal work on defining the molecular genetic basis for the ABO blood group system. After receiving his Ph.D. in Developmental and Cellular Biology from the Osaka City University, in Japan, he worked for many years in the USA, at the State University of New York at Stony Brook, at the University of Washington-affiliated non-profit research institute, at The Biomembrane Institute, and at the Sanford-Burnham Prebys Medical Discovery Institute.

After working in the USA, Dr. Yamamoto moved to Spain. He first worked in the Institute of Predictive and Personalized Medicine of Cancer (IMPPC), and afterward, he joined the Josep Carreras Leukaemia Research Institute (IJC). He leads the research group of Immunohematology and Glycobiology in the IJC, contributing to a better understanding of glycosylation polymorphisms and cancer-specific glycosylation alterations, as well as the development of novel immunotherapy that targets those alterations.

The Karl Landsteiner Award is the latest of a string of international awards for Dr. Yamamoto's work on blood groups: The Jean Julliard Prize from the International Society of Blood Transfusion, the Keynote Lecture Award from the Japanese Society of Blood Transfusion, and the French Diplome de Docteur Honoris Causa from the University of Toulouse.